Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Discontinue PRN Psychotropic Medication After 14 Days

Allen, Texas Survey Completed on 05-22-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident was free from chemical restraints that were not required to treat medical symptoms. Specifically, a male resident with a history of nontraumatic intracerebral hemorrhage, quadriplegia, and restlessness/agitation was prescribed Xanax 0.5mg as a PRN antianxiety medication. The physician's order for Xanax did not specify an end date, and the medication was administered on multiple occasions over a period exceeding 14 days. There was no documented rationale for the continued provision of the medication beyond the 14-day period. The resident's care plan indicated the use of antianxiety medication for anxiety disorder, with goals to avoid discomfort or adverse reactions. However, the facility did not discontinue the PRN prescription after 14 days as required, nor did it document a justification for ongoing use. During an interview, the DON acknowledged the expectation that PRN psychotropic medications should not be prescribed for more than 14 days and was unable to explain why the order remained active. Additionally, the facility did not have a written policy regarding PRN antianxiety/psychotropic medication use.

An unhandled error has occurred. Reload 🗙